Iso-LSD
| Clinical data | |
|---|---|
| Other names | IsoLSD; I-LSD; d-Iso-LSD; (+)-Iso-LSD; (5R-8S)-LSD; Isolysergic acid diethylamide; N,N-Diethylisolysergamide; iso-Lysergic acid diethylamide; N,N-Diethyl-6-methyl-9,10-didehydroergoline-8α-carboxamide; d-Isolysergic acid diethylamide |
| Routes of administration | Oral |
| Drug class | Serotonin receptor modulator |
| ATC code |
|
| Pharmacokinetic data | |
| Elimination half-life | 12 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.387.572 |
| Chemical and physical data | |
| Formula | C20H25N3O |
| Molar mass | 323.440 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Iso-LSD, also known as d-iso-LSD, (+)-iso-LSD, or (5R-8S)-LSD, as well as N,N-diethylisolysergamide, is a serotonin receptor modulator of the lysergamide family related to lysergic acid diethylamide (LSD). It is the 8-position epimer of LSD, with iso-LSD being 8α (8S) and LSD being 8β (8R). Iso-LSD is also the N,N-diethyl derivative of isoergine (isolysergic acid amide; iso-LSA), a constituent found in morning glory seeds. Iso-LSD is one of four possible stereoisomers of LSD.